Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2026-01-06 @ 3:46 PM
Study NCT ID:
NCT03045393
Status:
WITHDRAWN
Last Update Posted:
2018-07-05
First Post:
2017-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-17
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-03
First Submit QC Date:
None
Study First Post Date:
2017-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-02
Last Update Post Date:
2018-07-05
Last Update Post Date Type:
ACTUAL